Medical Claim Cost Impact of Improved Diabetes Control for Medicare and Commercially Insured Patients with Type 2 Diabetes

BACKGROUND: Diabetes prevalence is increasing in the United States, yet the control of critical clinical metrics (e.g., hemoglobin A1c [A1c], blood pressure, and lipids) remains suboptimal. Lower A1c levels have been shown to be associated with lower diabetes complication rates, and reduced medical...

Descripción completa

Detalles Bibliográficos
Autores principales: Fitch, Kathryn, Pyenson, Bruce S., Iwasaki, Kosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437463/
https://www.ncbi.nlm.nih.gov/pubmed/24074007
http://dx.doi.org/10.18553/jmcp.2013.19.8.609

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437463/
https://www.ncbi.nlm.nih.gov/pubmed/24074007
http://dx.doi.org/10.18553/jmcp.2013.19.8.609

Ejemplares similares